Back to Search
ERIC RUDERMAN, MD
MD
Rheumatology Physician
NPI: 1871526657IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
CMS Specialties
PrimaryRHEUMATOLOGY
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1987
Research & Publications (18)
Drug Insight: abatacept for the treatment of rheumatoid arthritis.
PMID 17133250·Nat Clin Pract Rheumatol·2006
6-review
The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis.
PMID 15833145·Arthritis Res Ther·2005
6-review
Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist.
PMID 15450343·Dermatol Clin·2004
4-observational
Evaluation and management of psoriatic arthritis: the role of biologic therapy.
PMID 12894136·J Am Acad Dermatol·2003
6-review
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages.
PMID 19189309·Eur J Immunol·2009
7-preclinical
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
PMID 18576334·Arthritis Rheum·2008
4-observational
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
PMID 16488334·J Am Acad Dermatol·2006
6-review
Systematic review of studies of productivity loss due to rheumatoid arthritis.
PMID 16286432·Occup Med (Lond)·2006
1-meta
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
PMID 16200601·Arthritis Rheum·2005
3-trial
Current and future pharmaceutical therapy for rheumatoid arthritis.
PMID 15720281·Curr Pharm Des·2005
6-review
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction.
PMID 15580917·Postgrad Med·2004
6-review
Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
PMID 15290730·J Rheumatol·2004
3-trial
Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
PMID 11990862·Am J Manag Care·2002
6-review
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
PMID 12416946·Ann Intern Med·2002
3-trial
Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial.
PMID 19078452·J Clin Rheumatol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 680 N LAKE SHORE DR, SUITE 1000
CHICAGO, IL 60611 - Phone
- (312) 695-9797
Quick Facts
- NPI
- 1871526657
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 18
Are you this provider?
Claim Your Profile